search
Back to results

Equivalence of a Human-Powered Nebulizer to an Electric Nebulizer

Primary Purpose

Asthma

Status
Completed
Phase
Phase 2
Locations
El Salvador
Study Type
Interventional
Intervention
Human-Powered Nebulizer
Sponsored by
Marquette University
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Asthma focused on measuring Asthma, Nebulizers, Salbutamol, Developing Countries

Eligibility Criteria

6 Years - 65 Years (Child, Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  • Suffering from Mild or Moderate Asthma symptoms
  • Increased respiratory rate, but not over 30 breaths per minute
  • Reduced peak expiratory flow rate, but not less than 60% of normal
  • Oxygen saturation levels reduced but greater than 90%

Exclusion Criteria:

  • Any other respiratory condition that would interfere with nebulizer treatment
  • If any other medication is being taken at the time
  • Pregnant women or women who may think they might be pregnant
  • Never taken salbutamol before

Sites / Locations

  • Hospital Nacional San Bartolo

Arms of the Study

Arm 1

Arm 2

Arm Type

Active Comparator

Experimental

Arm Label

Electric Nebulizer

Human-Powered Nebulizer

Arm Description

Pulmo-Aide Model 5650D

Human-Powered

Outcomes

Primary Outcome Measures

Improvement in Peak Expiratory Flow

Secondary Outcome Measures

Improvement in blood oxygenation as measured by pulse oximetry

Full Information

First Posted
February 3, 2013
Last Updated
February 18, 2013
Sponsor
Marquette University
search

1. Study Identification

Unique Protocol Identification Number
NCT01795742
Brief Title
Equivalence of a Human-Powered Nebulizer to an Electric Nebulizer
Official Title
Equivalence of a Human-Powered Nebulizer to an Electric Nebulizer in the Treatment of Mild to Moderate Asthma in El Salvador
Study Type
Interventional

2. Study Status

Record Verification Date
February 2013
Overall Recruitment Status
Completed
Study Start Date
August 2012 (undefined)
Primary Completion Date
October 2012 (Actual)
Study Completion Date
October 2012 (Actual)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
Marquette University

4. Oversight

Data Monitoring Committee
No

5. Study Description

Brief Summary
This is an equivalence study comparing an electric nebulizer with a human-powered nebulizer--one that does not need electricity--in the treatment of mild to moderate asthma exacerbations in a regional clinic in San Salvador, El Salvador.
Detailed Description
The study design is to treat individuals suffering from mild to moderate exacerbations of asthma with nebulized salbutamol (2.5mg). Subjects will receive nebulization using either an electric nebulizer compressor or a human-powered nebulizer compressor. Improvement in peak expiratory flow will be the primary endpoint. Blood oxygenation levels as measured by pulse oximetry will be a secondary endpoint of the trial.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Asthma
Keywords
Asthma, Nebulizers, Salbutamol, Developing Countries

7. Study Design

Primary Purpose
Treatment
Study Phase
Phase 2
Interventional Study Model
Parallel Assignment
Masking
None (Open Label)
Allocation
Randomized
Enrollment
110 (Actual)

8. Arms, Groups, and Interventions

Arm Title
Electric Nebulizer
Arm Type
Active Comparator
Arm Description
Pulmo-Aide Model 5650D
Arm Title
Human-Powered Nebulizer
Arm Type
Experimental
Arm Description
Human-Powered
Intervention Type
Device
Intervention Name(s)
Human-Powered Nebulizer
Primary Outcome Measure Information:
Title
Improvement in Peak Expiratory Flow
Time Frame
From before to after nebulizer treatment lasting approximately 30 minutes
Secondary Outcome Measure Information:
Title
Improvement in blood oxygenation as measured by pulse oximetry
Time Frame
From before to after nebulizer treatment lasting about 30 minutes

10. Eligibility

Sex
All
Minimum Age & Unit of Time
6 Years
Maximum Age & Unit of Time
65 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: Suffering from Mild or Moderate Asthma symptoms Increased respiratory rate, but not over 30 breaths per minute Reduced peak expiratory flow rate, but not less than 60% of normal Oxygen saturation levels reduced but greater than 90% Exclusion Criteria: Any other respiratory condition that would interfere with nebulizer treatment If any other medication is being taken at the time Pregnant women or women who may think they might be pregnant Never taken salbutamol before
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Lars E Olson, Ph.D.
Organizational Affiliation
Marquette University
Official's Role
Principal Investigator
Facility Information:
Facility Name
Hospital Nacional San Bartolo
City
Ilopango
State/Province
San Salvador
Country
El Salvador

12. IPD Sharing Statement

Citations:
PubMed Identifier
24965834
Citation
Hallberg CJ, Lysaught MT, Najarro RA, Cea Gil F, Villatoro C, Diaz de Uriarte AC, Olson LE. Treatment of asthma exacerbations with the human-powered nebuliser: a randomised parallel-group clinical trial. NPJ Prim Care Respir Med. 2014 Jun 26;24:14016. doi: 10.1038/npjpcrm.2014.16.
Results Reference
derived

Learn more about this trial

Equivalence of a Human-Powered Nebulizer to an Electric Nebulizer

We'll reach out to this number within 24 hrs